A traditional Chinese medicine preparation for preventing and treating cardiac and cerebrovascular disease in the elderly and a preparing method thereof

Abstract

A traditional Chinese medicine preparation for preventing and treating cardiac and cerebrovascular disease in the elderly and a preparing method thereof are disclosed. The preparation is prepared from following raw materials by weight: 1-700 parts of radix codonopsis, 1-600 parts of giant knot weed, 1-600 parts of root of kudzu vine, 1-800 parts of radix astragali, 1-600 parts of Chinese angelica, 1-600 parts of ligusticum wallichii, 1-300 parts of earthworm, 1-300 parts of morinda officinalis, 1-300 parts of herba epimedii, 1-600 parts of hawthorn, 1-400 parts of bamboo leaf, 1-300 parts of mint, 10-600 parts of oligosaccharides, 1-300 parts of fructose-1,6-diphosphate and 1500-100000 parts of water. The preparation and the preparing method have characteristics of low cost, convenient carrying dosage, stable content, reliable curative effects, capability of verification and being natural, and no toxicity. The preparation is suitable for long-term medication of the elderly with cardiovascular and cerebrovascular diseases in the low-risk period and the medium-risk period in the masses, and suitable for combined treatment of traditional Chinese medicines and western medicines in the high-risk period.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a traditional Chinese medicine preparation for preventing and treating senile cardiovascular and cerebrovascular diseases with high safety, stable quality, low price, overall regulation and remarkable effect, and a preparation method thereof. Background technique [0002] Atherosclerosis (AS) is the pathological essence of cardiovascular and cerebrovascular diseases, and its complications such as angina pectoris, myocardial infarction, sudden cardiac death, cerebral vasospasm, cerebral embolism, and cerebral hemorrhage seriously endanger human health and life. In my country's "National Medium and Long-Term Science and Technology Development Plan (2006-2020)", "cardiovascular and cerebrovascular disease" prevention and treatment research is a key field and its priority theme. [0003] Current status of drugs for the prevention and treatment of cardiovascular and cerebr...

AI Technical Summary

Problems solved by technology

However, according to the analysis of existing traditional Chinese medicine products on the market, according to the guidance of the two major medical theory systems of Chinese and Western medicine, there is no traditional Chinese medicine product for the overall treatment of chronic blood stasis. In addition to common products in the formula, it is difficult to see traditional Chinese medicines related to nourishing the brain and calming the nerves, warming the spleen and kidney, regulating metabolism, diuresis and laxative, anti-oxidation, and supplementing phytoestrogens in the same formula, so there are many products in the formula. There is a problem of incomplete medicine

The second is the use of poisonous and cold Chinese medicines, which are effective in first aid and long-term use. Cold medicines can easily cause general fatigue, and toxic Chinese medicines can easily damage the liver and kidneys. The fourth is the two patents declared by the applicant in 2013: "Chinese medicine preparation for preventing and treating coronary heart disease and its preparation method", "Chinese medicine preparation for preventing and treating ischemic cerebrovascular disease and its preparation method" , through clinical research, it is suitable for the treatment of cardiovascular and cerebrovascular diseases in young people (in good overall condition), but the therapeutic effect on cardiovascular and cerebrovascular diseases in the elderly (in poor overall condition) is not ideal.

Images